Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
Apexigen, a California antibody company with strong...
3SBio acquired China rights for a novel...
JHL Biotech, a Taiwan-China biopharma that develops...
Sino Biopharma plans to invest up to $129 million in...
Baiyunshan Pharma will raise $1.6 billion in a secondary...
MicroConstants China in-licensed global rights to novel...
Last week, Regenerx was awarded a patent in China for its...
China's economy made an indelible impression on the world...
The ChinaBio® Stock Index, comprised of 17...
Ascenta Therapeutics of the US has struck a deal to...
Upcoming Events
BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here
Register here
Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events
Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here